239 related articles for article (PubMed ID: 21481872)
1. Statins exert differential effects on angiotensin II-induced atherosclerosis, but no benefit for abdominal aortic aneurysms.
Wang JA; Chen WA; Wang Y; Zhang S; Bi H; Hong B; Luo Y; Daugherty A; Xie X
Atherosclerosis; 2011 Jul; 217(1):90-6. PubMed ID: 21481872
[TBL] [Abstract][Full Text] [Related]
2. Chinese red yeast rice attenuates the development of angiotensin II-induced abdominal aortic aneurysm and atherosclerosis.
Xie X; Wang Y; Zhang S; Zhang G; Xu Y; Bi H; Daugherty A; Wang JA
J Nutr Biochem; 2012 Jun; 23(6):549-56. PubMed ID: 21764282
[TBL] [Abstract][Full Text] [Related]
3. Atorvastatin inhibits the 5-lipoxygenase pathway and expression of CCL3 to alleviate atherosclerotic lesions in atherosclerotic ApoE knockout mice.
Yang LX; Heng XH; Guo RW; Si YK; Qi F; Zhou XB
J Cardiovasc Pharmacol; 2013 Aug; 62(2):205-11. PubMed ID: 23615158
[TBL] [Abstract][Full Text] [Related]
4. Combination therapy with atorvastatin and amlodipine suppresses angiotensin II-induced aortic aneurysm formation.
Takahashi K; Matsumoto Y; Do e Z; Kanazawa M; Satoh K; Shimizu T; Sato A; Fukumoto Y; Shimokawa H
PLoS One; 2013; 8(8):e72558. PubMed ID: 23967318
[TBL] [Abstract][Full Text] [Related]
5. [Impact of rosuvastatin on atherosclerosis lesions in apolipoprotein E knockout mice].
Luo RN; Tao LJ; Zhou J; Wang R; Lu MM; Fu X
Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Aug; 39(8):743-8. PubMed ID: 22169423
[TBL] [Abstract][Full Text] [Related]
6. Rosuvastatin attenuates atherosclerosis in rats via activation of scavenger receptor class B type I.
Li Y; Wang Q; Zhou J; Xu Q; Chu X; Sun T; Liu X; Cai S
Eur J Pharmacol; 2014 Jan; 723():23-8. PubMed ID: 24333476
[TBL] [Abstract][Full Text] [Related]
7. Aliskiren limits abdominal aortic aneurysm, ventricular hypertrophy and atherosclerosis in an apolipoprotein-E-deficient mouse model.
Seto SW; Krishna SM; Moran CS; Liu D; Golledge J
Clin Sci (Lond); 2014 Jul; 127(2):123-34. PubMed ID: 24476071
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of endoplasmic reticulum stress signaling pathway: A new mechanism of statins to suppress the development of abdominal aortic aneurysm.
Li Y; Lu G; Sun D; Zuo H; Wang DW; Yan J
PLoS One; 2017; 12(4):e0174821. PubMed ID: 28369137
[TBL] [Abstract][Full Text] [Related]
9. Rosuvastatin activates ATP-binding cassette transporter A1-dependent efflux ex vivo and promotes reverse cholesterol transport in macrophage cells in mice fed a high-fat diet.
Shimizu T; Miura S; Tanigawa H; Kuwano T; Zhang B; Uehara Y; Saku K
Arterioscler Thromb Vasc Biol; 2014 Oct; 34(10):2246-53. PubMed ID: 25104799
[TBL] [Abstract][Full Text] [Related]
10. Mas receptor deficiency augments angiotensin II-induced atherosclerosis and aortic aneurysm ruptures in hypercholesterolemic male mice.
Stegbauer J; Thatcher SE; Yang G; Bottermann K; Rump LC; Daugherty A; Cassis LA
J Vasc Surg; 2019 Nov; 70(5):1658-1668.e1. PubMed ID: 30850299
[TBL] [Abstract][Full Text] [Related]
11. Rosuvastatin prevents endothelial cell death and reduces atherosclerotic lesion formation in ApoE-deficient mice.
Enomoto S; Sata M; Fukuda D; Nakamura K; Nagai R
Biomed Pharmacother; 2009 Jan; 63(1):19-26. PubMed ID: 18162361
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of development of experimental aortic abdominal aneurysm in rat model by atorvastatin through inhibition of macrophage migration.
Shiraya S; Miyake T; Aoki M; Yoshikazu F; Ohgi S; Nishimura M; Ogihara T; Morishita R
Atherosclerosis; 2009 Jan; 202(1):34-40. PubMed ID: 18482727
[TBL] [Abstract][Full Text] [Related]
13. Combined effects of HMG-CoA-reductase inhibition and renin-angiotensin system blockade on experimental atherosclerosis.
Grothusen C; Bley S; Selle T; Luchtefeld M; Grote K; Tietge UJ; Drexler H; Schieffer B
Atherosclerosis; 2005 Sep; 182(1):57-69. PubMed ID: 16115475
[TBL] [Abstract][Full Text] [Related]
14. Rosuvastatin displays anti-atherothrombotic and anti-inflammatory properties in apoE-deficient mice.
Monetti M; Canavesi M; Camera M; Parente R; Paoletti R; Tremoli E; Corsini A; Bellosta S
Pharmacol Res; 2007 May; 55(5):441-9. PubMed ID: 17350858
[TBL] [Abstract][Full Text] [Related]
15. Effect of atorvastatin on the expression of gamma-glutamyl transferase in aortic atherosclerotic plaques of apolipoprotein E-knockout mice.
Li G; Wu XW; Lu WH; Ai R; Chen F; Tang ZZ
BMC Cardiovasc Disord; 2014 Oct; 14():145. PubMed ID: 25326709
[TBL] [Abstract][Full Text] [Related]
16. Rosuvastatin inhibits MMP-2 expression and limits the progression of atherosclerosis in LDLR-deficient mice.
Guo H; Shi Y; Liu L; Sun A; Xu F; Chi J
Arch Med Res; 2009 Jul; 40(5):345-51. PubMed ID: 19766896
[TBL] [Abstract][Full Text] [Related]
17. Aliskiren inhibits atherosclerosis development and improves plaque stability in APOE*3Leiden.CETP transgenic mice with or without treatment with atorvastatin.
Kühnast S; van der Hoorn JW; van den Hoek AM; Havekes LM; Liau G; Jukema JW; Princen HM
J Hypertens; 2012 Jan; 30(1):107-16. PubMed ID: 22134386
[TBL] [Abstract][Full Text] [Related]
18. Aldosterone does not mediate angiotensin II-induced atherosclerosis and abdominal aortic aneurysms.
Cassis LA; Helton MJ; Howatt DA; King VL; Daugherty A
Br J Pharmacol; 2005 Feb; 144(3):443-8. PubMed ID: 15655500
[TBL] [Abstract][Full Text] [Related]
19. Rosuvastatin reduces atherosclerosis development beyond and independent of its plasma cholesterol-lowering effect in APOE*3-Leiden transgenic mice: evidence for antiinflammatory effects of rosuvastatin.
Kleemann R; Princen HM; Emeis JJ; Jukema JW; Fontijn RD; Horrevoets AJ; Kooistra T; Havekes LM
Circulation; 2003 Sep; 108(11):1368-74. PubMed ID: 12939225
[TBL] [Abstract][Full Text] [Related]
20. Rosuvastatin reduces atherosclerotic lesions and promotes progenitor cell mobilisation and recruitment in apolipoprotein E knockout mice.
Schroeter MR; Humboldt T; Schäfer K; Konstantinides S
Atherosclerosis; 2009 Jul; 205(1):63-73. PubMed ID: 19111832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
